lactose has been researched along with bx 471 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kranz, H; Le Brun, V; Wagner, T | 1 |
Kranz, H; Wagner, T | 1 |
2 other study(ies) available for lactose and bx 471
Article | Year |
---|---|
Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.
Topics: Calcium Phosphates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Stability; Fumarates; Hydrogen-Ion Concentration; Lactose; Phenylurea Compounds; Piperidines; Polyvinyls; Povidone; Receptors, CCR1; Receptors, Chemokine; Solubility; Starch; Tablets | 2005 |
Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
Topics: Calcium Phosphates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Stability; Excipients; Hydrogen-Ion Concentration; Hypromellose Derivatives; In Vitro Techniques; Lactose; Methylcellulose; Pharmaceutic Aids; Phenylurea Compounds; Piperidines; Povidone; Solubility; Starch; Tablets; Technology, Pharmaceutical; Temperature; Time Factors | 2006 |